Shares of Kailera Therapeutics fell 10% on Tuesday, a decline triggered by late-stage trial results showing that its oral ...
Vafseo® demonstrated a clinically meaningful safety outcome benefit in U.S. patients with anemia due to CKD on dialysis ...
The MASAI trial1 is an important step. Jessie Gommers and colleagues report non-inferiority for interval cancer rate with an artificial intelligence (AI)-supported workflow, alongside higher ...
Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.
The BrioVAD pump is the first implantable device from China to receive approval for clinical trials in America A "Chinese ...
This report presents the long-term follow-up results of JCOG1008, phase 2/3 trial comparing weekly cisplatin versus 3-weekly cisplatin for patients with postoperative high-risk locally advanced ...
Breakout Momentum Plays You May Not Know About; Eyepoint Pharmaceuticals (NASDAQ:EYPT) executives said the company remains on track to report top-line data from its Phase 3 wet ag ...
Medindia on MSN
Has Science Found a Way to Prevent Ozempic Butt?
India, June 24 -- A new study published in Nature Medicine suggests that Apitegromab, an investigational muscle-preserving ...
In Phase 3 trial in obesity/overweight in China, HRS-7535 achieved a mean weight loss of up to 10.9% at Week 44 and a mean weight loss of up to ...
4FRONT-1, the first 4D-150 wet AMD phase 3 trial, is being conducted in North America in treatment-naïve patients with an ...
At the American Society of Clinical Oncology (ASCO) meeting, results from the OPTIMA trial suggested that genomic testing may help identify additional patients with hormone ...
First and only oral carbapenem antibiotic approved in the USApproval based on PIVOT-PO trial demonstrating non-inferiority compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results